| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6175830 | European Urology | 2016 | 4 Pages |
Abstract
Clinical lymph node metastases are not a factor in determining survival after radical prostatectomy and pelvic lymph node dissection in patients with prostate cancer. Thus, the presence of clinical lymph node metastases should not be considered as an absolute contraindication to treatment with curative intent.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Marco Moschini, Alberto Briganti, Christopher R. Murphy, Marco Bianchi, Giorgio Gandaglia, Francesco Montorsi, J. Fernando Quevedo, Rachel Carlson, Eugene Kwon, R. Jeffrey Karnes,